Skip to main content
Scientific Reports logoLink to Scientific Reports
editorial
. 2022 Nov 28;12:20497. doi: 10.1038/s41598-022-24850-x

Genome editing

Maura McGrail 1,✉, Tetsushi Sakuma 2, Leonidas Bleris 3
PMCID: PMC9705536  PMID: 36443399

Abstract

Recent advances in genome editing technologies have redefined our ability to probe and precisely edit the human genome and epigenome in vitro and in vivo. More specifically, RNA-guided CRISPR/Cas systems have revolutionized the field due to their simplicity in design and adaptability across biological systems. This Collection highlights results in CRISPR/Cas technology that increase the efficiency of precision genome editing, and allow genetic manipulation in model systems traditionally intractable to site-directed gene modification.

Subject terms: Mutagenesis, Epigenomics


The development of custom Cas9 endonucleases for CRISPR/Cas9 genome editing has revolutionized the field of genetics and functional genomics1–3. CRISPR/Cas9 targeting of a DNA double strand break provides a template for cellular repair mechanisms that introduce mutations through error-prone Non-Homologous End Joining, or allow precision knock-in of exogenous sequences by Homology Directed Repair4–11. The utility of CRISPR/Cas9 editing has been greatly expanded by engineering of Cas9 variants with single strand nicking activity to reduce off-target genome edits6, altered protospacer adjacent motif (PAM) recognition sequences to broaden the targetable genome12–15, and inactivated enzymes which lack endonuclease activity (dCas9)16. dCas9 variants create a platform for generation of fusion proteins with novel gene editing function, including epigenome editing through regulation of histone modifications17–21, deaminases that modify nucleotide sequences through base editing22,23, and reverse transcriptase which introduces genome edits from an RNA template through prime editing24. These powerful Cas9-based genome editing tools allow targeted modification of nearly any gene of interest across most biological systems, enabling molecular genetic studies in organisms in which gene manipulation and transgenesis has traditionally been difficult25,26. Key considerations in the application of this technology are optimal delivery and expression of CRISPR/Cas9 reagents.

This Collection gathers 17 contributions describing new methods to improve CRISPR/Cas9 genome editing efficiency in a variety of animal and plant systems27–34, and its application to develop new genetic tools and models35–38 and to gain novel insight into mechanisms regulating organismal physiology, cell behavior, and gene expression39–43.

The relatively low efficiency of CRISPR/Cas9 targeted integration of exogenous DNA via HDR has been a limiting factor in precision knock-in in mammalian cells and in vivo systems in which the predominant DNA repair pathway is Non-Homologous End Joining (NHEJ). Optimization of each parameter in CRISPR knock-in experimental design, including the specific Cas endonuclease, single or double-stranded DNA template, linear or circular templates, and homology arm length increases the chances of recovering precision HDR edits. For gene editing in mammalian cells using single-stranded oligonucleotide templates, guide RNA selection, donor strand preference, and introduction of blocking mutations in the template to prevent cleavage, together lead to significantly higher frequencies of on target precision integration27. Experimental manipulation to enhance HDR knock-ins involve altering the relative activity of different DNA repair pathways by inhibition of the NHEJ DNA repair enzymes DNA Polymerase θ and DNA-PK, in combination with in vivo template liberation28.

An important consideration in optimizing gene editing experimental design is the need for efficient delivery and robust expression of CRISPR/Cas9 editing reagents in individual systems. Replacement of Drosophila gene promoters in CRISPR/Cas9 targeting plasmids with Aedes aegypti counterparts lead to high level Cas9 and gRNA gene expression, and the efficient recovery of knock-in edited mosquito cell lines expressing Flag-tagged AGO1 for future functional studies30. Use of an endogenous RPS5a promoter for expression of deaminase base editors in Arabidopsis thaliana increased base editing efficiency > 30% in comparison to the heterologous CaMV35S viral promoter34. These studies underscore species-specific gene regulatory elements may be required for optimal gene editing in some systems. Generating genetically modified mice by gene editing was shown to be facilitated by an Integrated Automated Embryo Manipulation System, that positions mouse embryos for reproducible pronuclear microinjection31. Optimal injection conditions allowed efficient introduction of gene edits and increased embryo survival, enhancing the recovery of genome edited adult mice. In difficult to transfect cells such as human iPSCs, a piggyBac transposon system provided sustained expression of Cas9 prime editors, a critical factor when combined with optimal pegRNA template design, for efficient gene editing29. Recovery of patient derived CRISPR-Cas9 knockout leukemia cells was significantly improved by the development of a fluorescent reporter system that provides a readout of cells harboring high levels of gene editing38.

The Cas9 targetable genome has been significantly expanded with the development of near-PAM-less Cas9 variants that recognize NG, NA, NT and NC PAMs. In Dictyostelium discoidium cells near-PAM-less Cas9 variants were compared and shown to promote efficient knock-in of a double-stranded fluorescence reporter template or single-stranded oligos harboring single nucleotide changes32. Application of genome editing in D. discoidium, an in vivo system for investigating molecular mechanisms in the evolution of multi-cellular organisms, now allows investigators to examine the genetic requirements for multicellular communication and coordinated cell–cell interactions. As an alternative to Cas9-induced double strand breaks to stimulate HDR, tandem paired nicking using Cas9 D10A nickases, with long homology templates of 1700–2000 bp and an optimal 20 nucleotide gRNA length, drove efficient precise knock-in in HCT116 cells33, suggesting the potential for applying TPN targeting in other cell types.

CRISPR-directed knock-in and knock-out have been widely applied to generate novel genetic tools and models to investigate gene function. The CRISPR/Cas9 GeneWeld short homology arm knock-in approach for generating targeted integrations44 was used to integrate Cre recombinase into zebrafish proneural genes, placing Cre expression under the control of endogenous gene regulatory elements to increase the specificity and reproducibility of Cre recombinase activity for improved cell lineage labeling and conditional gene studies35. Application of PITCh (Precise Integration into Target Chromosome)45 to target the Ca2 + sensor GCaMP3 into the midge Polypedilum vanderplanki Pv11 cells suggests an important role for calcium signaling in anhydrobiosis in midge larvae40. HDR has also been used to increase the robustness of PD-L1 gene knock-down in cultured glioblastoma cells, by introducing a template harboring a stop codon, revealing a critical role for PD-L1 in preventing proliferation, invasion and tumor associated macrophage polarization to M1 phenotype39.

The high efficiency of CRISPR knockout with single or dual gRNAs targeting exons has generated multiple new genetic models including investigation of the role of exon skipping in frame-shift mutant alleles in mice36, the role of HOL methyltransferases in methyl iodide emission from rice Oryza sativa41, and patient derived cultured myoblast models of Duchenne muscular dystrophy for chemical screens37. CRISPR/Cas9-guided promoter deletion is also an effective method for gene knock-down as shown by H19 lncRNA knock-out impacting cell proliferation and genome stability42. Double strand and single strand break-free methods for silencing gene expression using epigenome editors allows direct demonstration of the relationship between H3K27Ac in gene promoter leading to H3K4me3 enrichment43, providing an elegant, non-mutagenic approach to investigate crosstalk in epigenetic mechanisms regulating transcriptional activation.

The papers published in this Collection highlight how optimal experimental design and development of species specific reagents enhance the efficiency of CRISPR/Cas9 genome editing. These advances illustrate the tremendous power of CRISPR/Cas9 genome editing to open new areas of investigation and allow genetic manipulation in model systems traditionally intractable to site-directed gene modification.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Jinek M, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–821. doi: 10.1126/science.1225829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science. 2010;327:167–170. doi: 10.1126/science.1179555. [DOI] [PubMed] [Google Scholar]
  • 3.Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. USA. 2012;109:E2579–2586. doi: 10.1073/pnas.1208507109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chang N, et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 2013;23:465–472. doi: 10.1038/cr.2013.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013;31:230–232. doi: 10.1038/nbt.2507. [DOI] [PubMed] [Google Scholar]
  • 6.Cong L, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339:819–823. doi: 10.1126/science.1231143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Friedland AE, et al. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods. 2013;10:741–743. doi: 10.1038/nmeth.2532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gratz SJ, et al. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics. 2013;194:1029–1035. doi: 10.1534/genetics.113.152710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mali P, et al. RNA-guided human genome engineering via Cas9. Science. 2013;339:823–826. doi: 10.1126/science.1232033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Wang H, et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell. 2013;153:910–918. doi: 10.1016/j.cell.2013.04.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Yang H, et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell. 2013;154:1370–1379. doi: 10.1016/j.cell.2013.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kleinstiver BP, et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature. 2015;523:481–485. doi: 10.1038/nature14592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Walton RT, Christie KA, Whittaker MN, Kleinstiver BP. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science. 2020;368:290–296. doi: 10.1126/science.aba8853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Hu JH, et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature. 2018;556:57–63. doi: 10.1038/nature26155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nishimasu H, et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science. 2018;361:1259–1262. doi: 10.1126/science.aas9129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Qi LS, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 2013;152:1173–1183. doi: 10.1016/j.cell.2013.02.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kearns NA, et al. Functional annotation of native enhancers with a Cas9-histone demethylase fusion. Nat. Methods. 2015;12:401–403. doi: 10.1038/nmeth.3325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hilton IB, et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 2015;33:510–517. doi: 10.1038/nbt.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Kim JM, et al. Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells. Nucleic Acids Res. 2015;43:8868–8883. doi: 10.1093/nar/gkv874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cano-Rodriguez D, et al. Writing of H3K4Me3 overcomes epigenetic silencing in a sustained but context-dependent manner. Nat. Commun. 2016;7:12284. doi: 10.1038/ncomms12284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kwon DY, Zhao YT, Lamonica JM, Zhou Z. Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC. Nat. Commun. 2017;8:15315. doi: 10.1038/ncomms15315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420–424. doi: 10.1038/nature17946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nishida K, et al. Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems. Science. 2016 doi: 10.1126/science.aaf8729. [DOI] [PubMed] [Google Scholar]
  • 24.Anzalone AV, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149–157. doi: 10.1038/s41586-019-1711-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Komor AC, Badran AH, Liu DR. CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes. Cell. 2017;169:559. doi: 10.1016/j.cell.2017.04.005. [DOI] [PubMed] [Google Scholar]
  • 26.Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096. doi: 10.1126/science.1258096. [DOI] [PubMed] [Google Scholar]
  • 27.Schubert MS, et al. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair. Sci. Rep. 2021;11:19482. doi: 10.1038/s41598-021-98965-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Arai D, Nakao Y. Efficient biallelic knock-in in mouse embryonic stem cells by in vivo-linearization of donor and transient inhibition of DNA polymerase theta/DNA-PK. Sci. Rep. 2021;11:18132. doi: 10.1038/s41598-021-97579-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Eggenschwiler R, et al. A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines. Sci. Rep. 2021;11:22154. doi: 10.1038/s41598-021-01689-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Rozen-Gagnon K, Yi S, Jacobson E, Novack S, Rice CM. A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines. Sci. Rep. 2021;11:736. doi: 10.1038/s41598-020-80436-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eto T, et al. Establishment of an integrated automated embryonic manipulation system for producing genetically modified mice. Sci. Rep. 2021;11:11770. doi: 10.1038/s41598-021-91148-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Asano Y, et al. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum. Sci. Rep. 2021;11:11163. doi: 10.1038/s41598-021-89546-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rahman ML, et al. Experimental strategies to achieve efficient targeted knock-in via tandem paired nicking. Sci. Rep. 2021;11:22627. doi: 10.1038/s41598-021-01978-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Choi M, Yun JY, Kim JH, Kim JS, Kim ST. The efficacy of CRISPR-mediated cytosine base editing with the RPS5a promoter in Arabidopsis thaliana. Sci. Rep. 2021;11:8087. doi: 10.1038/s41598-021-87669-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Almeida MP, et al. Endogenous zebrafish proneural Cre drivers generated by CRISPR/Cas9 short homology directed targeted integration. Sci. Rep. 2021;11:1732. doi: 10.1038/s41598-021-81239-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kishimoto Y, et al. A novel tissue specific alternative splicing variant mitigates phenotypes in Ets2 frame-shift mutant models. Sci. Rep. 2021;11:8297. doi: 10.1038/s41598-021-87751-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Soblechero-Martin P, et al. Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening. Sci. Rep. 2021;11:18188. doi: 10.1038/s41598-021-97730-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Liu WH, Volse K, Senft D, Jeremias I. A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models. Sci. Rep. 2021;11:12649. doi: 10.1038/s41598-021-91760-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fierro J, Jr, et al. Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization. Sci. Rep. 2022;12:2417. doi: 10.1038/s41598-022-06430-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Miyata Y, et al. Cas9-mediated genome editing reveals a significant contribution of calcium signaling pathways to anhydrobiosis in Pv11 cells. Sci. Rep. 2021;11:19698. doi: 10.1038/s41598-021-98905-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Carlessi M, et al. Targeted knockout of the gene OsHOL1 removes methyl iodide emissions from rice plants. Sci. Rep. 2021;11:17010. doi: 10.1038/s41598-021-95198-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.da Silva Santos R, et al. CRISPR/Cas9 small promoter deletion in H19 lncRNA is associated with altered cell morphology and proliferation. Sci. Rep. 2021;11:18380. doi: 10.1038/s41598-021-97058-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhao W, et al. Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation. Sci. Rep. 2021;11:15912. doi: 10.1038/s41598-021-95398-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wierson WA, et al. Efficient targeted integration directed by short homology in zebrafish and mammalian cells. Elife. 2020 doi: 10.7554/eLife.53968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Nakade S, et al. Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9. Nat. Commun. 2014;5:5560. doi: 10.1038/ncomms6560. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES